Parker et al (2004) reported that PRL-3 is expressed in breast tumour vasculature. In other tumour entities, evidence of a causative role of PRL-3 in tumour-related angiogenesis has been demonstrated (Bardelli et al, 2003). This evidence concerns the gene PTP4A3 and breast neoplasm.